Alveron Pharma Announces €5M Seed Extension Financing To Accelerate Breakthrough Therapy For Intracranial HaemorrhageGrace Crocker2024-12-09T14:20:07+00:00December 9th, 2024|BioCity Nottingham, Investment|
World-Class ‘Accelerator’ To Speed Development Of Crucial Rehabilitation TechnologiesGrace Crocker2024-11-28T15:34:26+00:00November 21st, 2024|Investment, News|
How Pioneer Group’s Golden Ticket Programmes Are Fast-Tracking InnovationBeckie Barrett2024-11-28T14:22:22+00:00October 9th, 2024|Accelerator, Investment, News|
Novo Nordisk Partners With Pioneer Group To Launch The Golden Ticket ProgrammeGrace Crocker2024-12-05T10:36:15+00:00September 19th, 2024|Accelerator, Investment, News|
NanoSyrinx Closes c. £10 Million Financing And Appoints Dr Edwin Moses As ChairmanGrace Crocker2024-11-28T14:22:38+00:00September 11th, 2024|Investment, News|
What Are The Current Life Sciences Investment Trends?Beckie Barrett2024-08-21T14:19:26+01:00August 21st, 2024|Article, Investment|
MediCity Nottingham: 4D Medicine Raises £3.4m For Unique Biomaterial PlatformGrace Crocker2024-11-28T14:22:54+00:00July 26th, 2024|Investment, MediCity Nottingham, News|
Victoria House: The Centrepiece Of London Lab SpaceBeckie Barrett2024-11-28T16:47:15+00:00July 18th, 2024|Article, Investment|
Life Science Real Estate: A New Lease Of Life For The Golden TriangleBeckie Barrett2024-11-28T16:47:32+00:00July 12th, 2024|Article, Investment, The Crown Estate|
Government Initiatives For Life Sciences 2024: Latest DevelopmentsAmy Cotterill2024-05-30T16:50:42+01:00May 23rd, 2024|Article, Investment|
